Literature DB >> 15274330

Granulocyte/macrophage colony-stimulating factor and interleukin-4-induced dendritic cells.

Hajime Hikino1, Keizo Kasono, Masaki Kanzaki, Toshihiro Kai, Fumio Konishi, Masanobu Kawakami.   

Abstract

BACKGROUND: We investigated whether GM-CSF/IL-4 is the most efficient cytokine combination for differentiating dendritic cells (DC) in terms of its ability to elicit an antitumor immune response.
MATERIALS AND METHODS: Two experimental models were examined: C57BL/6 mice bearing MC38 cells and Balb/c mice bearing cachexia-inducible Colon-26 cells. After immunization with DC pulsed with whole tumor cell lysate, tumors were inoculated into the subcutis.
RESULTS: C57BL/6 mice immunized with lysate-pulsed DC effectively rejected the MC38 challenge and detectable MC38-specific cytotoxic lymphocytes (CTL) were observed. However, even those groups immunized with lysate-pulsed DC exhibited no protective immunity against Colon-26 challenge in Balb/c mice. Unexpectedly, mice inoculated with lysate-unpulsed DC showed an acceleration of cachectic progression (p=0.031) compared to control mice.
CONCLUSION: We speculate that GM-CSF/IL-4-induced DC promotes Th2-dominated immunity in Balb/c mice. Consideration might be given to which combination of cytokines is appropriate for the ex vivo differentiation of DC in tumor immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15274330

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Altered differentiation, diminished pathogenicity, and regulatory activity of myelin-specific T cells expressing an enhanced affinity TCR.

Authors:  Rajshekhar Alli; Phuong Nguyen; Terrence L Geiger
Journal:  J Immunol       Date:  2011-10-24       Impact factor: 5.422

Review 2.  Survival of monocytes and macrophages and their role in health and disease.

Authors:  Melissa Hunter; Yijie Wang; Tim Eubank; Christopher Baran; Patrick Nana-Sinkam; Clay Marsh
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.